| Fasting-mimicking Diet in Treatment of Depressive Symptoms in IBD (NCT05382897) | University of Alberta | 2022-07-01 |
| The Use of Butyrate Therapy in Pediatric Ulcerative Colitis (NCT05218850) | Children's Hospital Los Angeles | 2022-06-29 |
| Monitoring of Inflammatory Conditions (NCT05458531) | University of Nottingham | 2022-06-28 |
| Personalised Prediction of Disease Course in Ulcerative Colitis Using Multimodal Machine Learning - Part of the Presager Project (NCT05479617) | Copenhagen University Hospital, Hvidovre | 2022-06-20 |
| Efficacy of Energy Therapy in the Management of Chronic Pain Medical Condition in Children and Adolescents. (NCT05394272) | King's College Hospital NHS Trust | 2022-06-15 |
| Remote Monitoring of IBD (NCT05886322) | Maastricht University Medical Center | 2022-06-07 |
| LFMT vs Placebo in New Biologic Start for Ulcerative Colitis (NCT05327790) | University of Alberta | 2022-06-03 |
| Investigation of the Effects of Curcumin and Resveratrol Supplements Added to the Mediterranean Diet on Disease Severity and Inflammatory Biomarkers in Patients With Ulcerative Colitis (NCT05761327) | Ardahan University | 2022-06-03 |
| Yuflyma® (Adalimumab), Patient Experience After Switching (NCT05427942) | Celltrion HealthCare France | 2022-06-03 |
| Carotegrast Methyl in Ulcerative Colitis (NCT06897150) | Takayuki Yamamoto | 2022-06-01 |
| Anal Manometry Examination in Patients With Ulcerative Colitis (NCT05488041) | Assaf-Harofeh Medical Center | 2022-06-01 |
| This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcerative Colitis Using Real World Data. (NCT05082428) | Pfizer | 2022-05-30 |
| The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients (NCT05246943) | The University of Texas Medical Branch, Galveston | 2022-05-25 |
| Genome Analysis Across Populations in Inflammatory Bowel Disease (NCT06042387) | Mount Sinai Hospital, Canada | 2022-05-01 |
| bIosimilar of aDalimumab, an European evAluation (NCT05190484) | Fresenius Kabi | 2022-04-30 |
| The Nori Health App (NCT05474742) | UMC Utrecht | 2022-04-25 |
| Real-world Effectiveness of Tofacitinib on Ulcerative Colitis Associated Spondyloarthropathy (NCT05431283) | Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) | 2022-04-25 |
| Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors (NCT04751396) | M.D. Anderson Cancer Center | 2022-04-20 |
| IBD and Women's Health Wellness Program (NCT05172557) | Mayo Clinic | 2022-04-14 |
| Sexual Dysfunction Among Inflammatory Bowel Disease Adults-Clinical Trial (NCT05230875) | University Hospital, Bordeaux | 2022-04-07 |
| Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Multicenter Cohort of Patients With Refractory Ulcerative Colitis. (NCT05728008) | IRCCS San Raffaele | 2022-04-05 |
| The Application of Transcriptomics in the Treatment of Ulcerative Colitis With Ustekinumab (NCT05896943) | Evangelismos Hospital | 2022-04-01 |
| Ulcerative Colitis Mayo Score With Artificial Intelligence (NCT05336773) | Third Military Medical University | 2022-04-01 |
| Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events (NCT05313620) | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | 2022-04-01 |
| Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes. (NCT05069259) | Pfizer | 2022-03-28 |
| Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis (NCT05019742) | Shanghai Pharma Biotherapeutics USA Inc. | 2022-03-21 |
| The Effect of MedicijnWijs on Adherence to Azathioprine Therapy in Adolescents With IBD (NCT05321485) | Maxima Medical Center | 2022-03-16 |
| FMT for Remission of Active Ulcerative Colitis in Adults (NCT04202211) | University of British Columbia | 2022-03-01 |
| The Effectiveness of Well-being Therapy on Mental Health and Self-efficacy of Patients With Ulcerative Colitis (NCT05645666) | Islamic Azad University, Isfahan (Khorasgan) Branch | 2022-03-01 |
| Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases (NCT05239702) | Zhejiang University | 2022-02-28 |
| Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care (NCT05221281) | The Hospital for Sick Children | 2022-02-25 |
| Effect and Mechanism of Dopamine on Ulcerative Colitis (NCT05214404) | Affiliated Hospital to Academy of Military Medical Sciences | 2022-02-16 |
| A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis (NCT05118919) | BioGaia Pharma AB | 2022-02-09 |
| Inflammatory Bowel Disease(IBD), Treatment Response (NCT05350644) | University of Southern Denmark | 2022-02-08 |
| The Nordic IBD Treatment Strategy Trial (NCT05180175) | Region Örebro County | 2022-02-07 |
| Prediction Model for Response to Biologics and Small Molecular Agent for UC (NCT05186623) | Asan Medical Center | 2022-02-05 |
| Assessment of the Effectiveness of Progressive Relaxation Techniques in Individuals With Ulcerative Colitis (NCT05788549) | Ege University | 2022-02-01 |
| Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis (NCT04987307) | Amgen | 2022-01-31 |
| Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis (NCT05205603) | Sixth Affiliated Hospital, Sun Yat-sen University | 2022-01-15 |
| A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis (NCT04898348) | KoBioLabs | 2022-01-14 |
| National GMA Post-market Clinical Follow-up Study (GRACE) (NCT05636709) | Adacyte Therapeutics SL | 2022-01-11 |
| CT to Assess the Efficacy and Safety of Adding GMA to Infliximab in Paediatric Patients With Steroid-refractory Ulcerative Colitis (NCT05430412) | Adacyte Therapeutics SL | 2022-01-11 |
| Microbiota and Probiotic Therapy in Ulcerative Colitis Patients (NCT07180186) | Tanta University | 2022-01-01 |
| A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Disease (NCT04804540) | Takeda | 2021-12-08 |
| Assessment of Patients With Acute Pouchitis Treated With Antibiotics (NCT05252273) | Alimentiv Inc. | 2021-12-07 |
| Quest to Analyze One Thousand Humans Meditating (NCT06583395) | Tobias Moeller-Bertram | 2021-12-05 |
| Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis (NCT05177835) | Abivax S.A. | 2021-12-03 |
| An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC) (NCT05084261) | Adiso Therapeutics | 2021-11-30 |
| The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis (NCT04985968) | InDex Pharmaceuticals | 2021-11-24 |
| Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative Colitis (NCT05404074) | InDex Pharmaceuticals | 2021-11-22 |
| Assessment of the Safety, Tolerability, and Pharmacokinetic of HM201 (NCT05088369) | Syneos Health | 2021-11-11 |
| Refined Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC) (NCT04968951) | Ari M Grinspan | 2021-11-10 |
| A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis (NCT05181137) | Reistone Biopharma Company Limited | 2021-11-05 |
| GI Permeability Change in Response to Aquamin® (NCT04855799) | James Varani | 2021-11-02 |
| Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial (NCT04835506) | Beth Israel Deaconess Medical Center | 2021-11-01 |
| Top Down Versus Step up in Pediatric Ulcerative Colitis (NCT04999228) | Children's Hospital of Fudan University | 2021-11-01 |
| Digital Behavioral Interventions in Inflammatory Bowel Disease (NCT04861597) | Montefiore Medical Center | 2021-11-01 |
| Assessment of 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients With Ulcerative Colitis in Korea (NCT04499495) | Ferring Pharmaceuticals | 2021-10-25 |
| The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic (NCT05098600) | Faculty Hospital Kralovske Vinohrady | 2021-10-15 |
| A Study of MK-6194 (PT101) in Participants With Active Ulcerative Colitis (UC) (MK-6194-002) (NCT04924114) | Merck Sharp & Dohme LLC | 2021-10-14 |
| Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD). (NCT04626947) | David Binion, MD | 2021-10-14 |
| Global IBD Visualization of Epidemiology Studies (GIVES) in the 21st Century (NCT04748627) | Chinese University of Hong Kong | 2021-10-01 |
| Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis (NCT04857112) | Bausch Health Americas, Inc. | 2021-09-29 |
| Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis (NCT04767984) | Northwestern University | 2021-09-24 |
| Clinical Study on the Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis With Depression (NCT05030064) | Third Military Medical University | 2021-09-10 |
| Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis (NCT05061446) | Pfizer | 2021-09-10 |
| Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease (NCT03935451) | McMaster University | 2021-09-01 |
| FIT Combining FC for Predicting MH and Histology Remission in UC (NCT05447572) | Shandong University | 2021-09-01 |
| Prospective Multicenter Trial to Determine the Efficacy and Outcome of the UCRI Biomarker Panel and Algorithm to Detect Mucosal Healing in Moderate to Severe Ulcerative Colitis Patients. (NCT04897282) | Glycominds, LLC | 2021-08-24 |
| MS-20 on Patients With Ulcerative Colitis(UC) (NCT04908644) | National Taiwan University Hospital | 2021-08-18 |
| Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis (NCT04624230) | Pfizer | 2021-08-12 |
| UC Cohort - The Influence of Diet on Gut Microbiotas (NCT04933162) | Mayo Clinic | 2021-08-03 |
| Assessment of Nutritional Knowledge in Patients With Inflammatory Bowel Disease (NCT04882566) | Assiut University | 2021-08-01 |
| A Study of Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumab in Japanese Clinical Practice (NCT04963725) | Janssen Pharmaceutical K.K. | 2021-07-18 |
| A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005) (NCT04996797) | Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2021-07-14 |
| Chronotherapy of 5-Aminosalicylic Acid in Ulcerative Colitis (NCT05213234) | Rush University Medical Center | 2021-07-09 |
| OPtical Diagnosis Training to Improve Dysplasia Characterisation in IBD (NCT04924543) | University of Birmingham | 2021-07-07 |
| Vitamin D Regulation of Gut Specific B Cells and Antibodies Targeting Gut Bacteria in Inflammatory Bowel Disease (NCT04828031) | Stanford University | 2021-07-01 |
| Multi-interventional Program to Reduce Chronic Ileoanal Pouch Leaks in UC (NCT04939025) | London North West Healthcare NHS Trust | 2021-07-01 |
| Digestive Biobank for Exploring Microbiota-host Interactions (NCT05704413) | Assistance Publique - Hôpitaux de Paris | 2021-06-17 |
| Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis (NCT04596293) | Bridge Biotherapeutics, Inc. | 2021-06-11 |
| Therapeutic Effect of New Biologics in Crohn's Disease (NCT04923100) | Sixth Affiliated Hospital, Sun Yat-sen University | 2021-06-10 |
| A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (NCT04738942) | Takeda | 2021-06-04 |
| Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis (NCT04882683) | Shandong Qilu Stem Cells Engineering Co., Ltd. | 2021-06-01 |
| Efficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative Colitis (NCT04478825) | Bridge Biotherapeutics, Inc. | 2021-06-01 |
| Registry and Biorepository for IBD in Central Texas (NCT04617184) | University of Texas at Austin | 2021-06-01 |
| A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD) (NCT05596422) | Takeda | 2021-05-27 |
| A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) (NCT04844606) | Eli Lilly and Company | 2021-05-26 |
| Digital Nutrition Therapy for Patients With IBD (NCT04653259) | University of Calgary | 2021-05-15 |
| A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis (NCT04877990) | Bristol-Myers Squibb | 2021-05-07 |
| Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis (NCT04862741) | Landos Biopharma Inc. | 2021-05-05 |
| Artificial Intelligence and Dysplasia Detection in Ulcerative Colitis (CUDISIA Study) (NCT05171634) | Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana | 2021-05-05 |
| The Contact Activation System and Ulcerative Colitis (NCT04621006) | Esbjerg Hospital - University Hospital of Southern Denmark | 2021-05-01 |
| Combination Therapy With Fecal Microbiota Transplantation and Vedolizumab for Induction of Ulcerative Colitis (NCT04231110) | McMaster University | 2021-05-01 |
| A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis (NCT04469062) | Eli Lilly and Company | 2021-04-20 |
| Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis (NCT04607837) | Pfizer | 2021-04-12 |
| Comparison of Two Different Golimumab Dosing Regimens for Ulcerative Colitis (NCT04156984) | David Drobne | 2021-04-07 |
| The Impact of Circadian Misalignment on Colonic Barrier Homeostasis in Ulcerative Colitis (NCT05180279) | Rush University Medical Center | 2021-04-01 |
| The Prediction of Anastomotic Insufficiency Risk After Colorectal Surgery (PANIC) Study (NCT04985981) | Michel Adamina, MD | 2021-04-01 |
| Hematological Indices and Fecal Calprotectin Predict Histological Remission in Ulcerative Colitis (NCT04818788) | Assiut University | 2021-04-01 |